MDM2 AMPLIFICATION, P53 MUTATION, AND P53 ACCUMULATION MALIGNANT FIBROUS HISTIOCYTOMA

被引：0
|
作者：
REID, AH
TSAI, MM
VENZON, DJ
WRIGHT, CF
LACK, EE
OLEARY, TJ
机构：
[1] ARMED FORCES INST PATHOL,WASHINGTON,DC 20306
[2] NCI,BETHESDA,MD 20892
[3] GEORGETOWN UNIV,SCH MED,WASHINGTON,DC
来源：
LABORATORY INVESTIGATION | 1995年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [41] P53 Gene mutation and expression of MDM2, P53, P16 protein and their relationship in human glioma
    Cui Wen
    Wu Renliang
    Cao Huiling
    Gao Jifa
    Wang Xu
    Ren Qiwei
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2005, 25 (6): : 622 - 624
  • [42] p53 immunoexpression in Barrett's adenocarcinoma:: p53 gene mutation vs binding to mdm2 oncoprotein
    Gírio, A
    Chaves, P
    Suspiro, A
    Afonso, A
    Pereira, AD
    Leitao, CN
    Almeida, MO
    Soares, J
    MODERN PATHOLOGY, 2002, 15 (01) : 127A - 127A
  • [43] p53 immunoexpression in Barrett's adenocarcinoma: p53 gene mutation vs binding to mdm2 oncoprotein
    Girio, A
    Chaves, P
    Suspiro, A
    Afonso, A
    Pereira, AD
    Leitao, CN
    Almeida, MO
    Soares, J
    LABORATORY INVESTIGATION, 2002, 82 (01) : 127A - 127A
  • [44] p53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines
    Taylor, AC
    Shu, LL
    Danks, MK
    Poquette, CA
    Shetty, S
    Thayer, MJ
    Houghton, PJ
    Harris, LC
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 35 (02): : 96 - 103
  • [45] MDM2 GENE AMPLIFICATION AND OVEREXPRESSION IN NONSMALL CELL LUNG CARCINOMAS WITH ACCUMULATION OF THE P53 PROTEIN IN THE ABSENCE OF P53 GENE-MUTATIONS
    MARCHETTI, A
    BUTTITTA, F
    PELLEGRINI, S
    MERLO, G
    CHELLA, A
    ANGELETTI, CA
    BEVILACQUA, G
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1995, 4 (02) : 93 - 97
  • [46] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [47] Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    D Chen
    Z Zhang
    M Li
    W Wang
    Y Li
    E R Rayburn
    D L Hill
    H Wang
    R Zhang
    Oncogene, 2007, 26 : 5029 - 5037
  • [48] Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors
    Yokoyama, R
    Schneider-Stork, R
    Radig, K
    Wex, T
    Roessner, A
    PATHOLOGY RESEARCH AND PRACTICE, 1998, 194 (09) : 615 - 621
  • [49] Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    Pant, Vinod
    Xiong, Shunbin
    Iwakuma, Tomoo
    Quintas-Cardama, Alfonso
    Lozano, Guillermina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 11995 - 12000
  • [50] MDM2 - arbiter of p53's destruction
    Lane, DP
    Hall, PA
    TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (10) : 372 - 374
12345